Rachel Saunders-Pullman

Rachel Saunders-Pullman publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Rachel Saunders-Pullman sits on this spectrum.

Rachel Saunders-Pullman D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Rachel Saunders-Pullman sits on this spectrum.

Best Publications

• LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

  Laurie J. Ozelius;Geetha Senthil;Rachel Saunders-Pullman;Erin Ohmann

  839
  Citations

• Metabolomic profiling to develop blood biomarkers for Parkinson's disease.

  Mikhail Bogdanov;Wayne R. Matson;Lei Wang;Theodore Matson

  493
  Citations

• Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia.

  Tania Fuchs;Sophie Gavarini;Rachel Saunders-Pullman;Rachel Saunders-Pullman;Deborah Raymond

  396
  Citations

• Mutations in GNAL cause primary torsion dystonia.

  Tania Fuchs;Rachel Saunders-Pullman;Rachel Saunders-Pullman;Ikuo Masuho;Marta San Luciano

  344
  Citations

• The effect of estrogen replacement on early Parkinson’s disease

  R. Saunders-Pullman;J. Gordon-Elliott;M. Parides;S. Fahn

  336
  Citations

• Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study

  Susan B Bressman;Susan B Bressman;Deborah Raymond;Tania Fuchs;Gary A Heiman

  229
  Citations

• Idiopathic torsion dystonia linked to chromosome 8 in two Mennonite families.

  L. Almasy;S. B. Bressman;D. Raymond;P. L. Kramer

  222
  Citations

• The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease

  Ziv Gan-Or;Laurie J. Ozelius;Anat Bar-Shira;Rachel Saunders-Pullman

  201
  Citations

• Arm swing as a potential new prodromal marker of Parkinson's disease.

  Anat Mirelman;Hagar Bernad-Elazari;Avner Thaler;Eytan Giladi-Yacobi

  186
  Citations

• Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium

  Karen Marder;Yuanjia Wang;Roy N Alcalay;Helen Mejia-Santana

  183
  Citations

• Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence.

  R. Saunders-Pullman;J. Shriberg;G. Heiman;D. Raymond

  178
  Citations

• Progression in the LRRK2-Asssociated Parkinson Disease Population.

  Rachel Saunders-Pullman;Anat Mirelman;Roy N Alcalay;Cuiling Wang

  174
  Citations

• Validity of spiral analysis in early Parkinson's disease

  Rachel Saunders‐Pullman;Rachel Saunders‐Pullman;Carol Derby;Kaili Stanley;Alicia Floyd

  174
  Citations

• GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder

  Ziv Gan‐Or;Ziv Gan‐Or;Anat Mirelman;Ronald B. Postuma;Isabelle Arnulf

  152
  Citations

• Etiology of musician's dystonia: familial or environmental?

  A. Schmidt;H. C. Jabusch;H. C. Jabusch;E. Altenmüller;J. Hagenah

  150
  Citations

• Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers

  Unknown

  141
  Citations

• Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?

  Rachel Saunders-Pullman

  135
  Citations

• High mutation rate in dopa-responsive dystonia: Detection with comprehensive GCHI screening

  J. Hagenah;R. Saunders-Pullman;K. Hedrich;K. Kabakci

  135
  Citations

• Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers.

  C. W. Hess;D. Raymond;P. de Carvalho Aguiar;S. Frucht

  132
  Citations

• Finding useful biomarkers for Parkinson’s disease

  Alice S. Chen-Plotkin;Roger Albin;Roy Alcalay;Debra Babcock

  129
  Citations